Colchicine for Secondary Prevention After Ischemic Stroke (CHANCE-3 EX)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 7500 participants.
Also called NCT07035405
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 7,500 participants
- Sponsor
- Registry
-
NCT07035405
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07035405. Randomized; quadruple masking; primary purpose prevention. Start 2025-07-04 (anticipated); primary completion 2028-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Colchicine for Secondary Prevention After Ischemic Stroke (CHANCE-3 EX)
- Condition
- Stroke
- Intervention (Drug)
- Colchicine 0.5 mg
- Intervention (Drug)
- Placebo colchicine
- Lead sponsor
- Beijing Tiantan Hospital
- Collaborator
- Shenzhen Medical Academy of Research and Translation
Record details
- Record id
cardio:ct-nct07035405- Content hash
4833a18a80b2ddbac480fa167c0be2172651c3cc746d85af28eda03e7e117e7f